azatoxin

Known as: 1H,6H-3-one-5,4,11,11a-tetrahydro-5-(3,5-dimethoxy-4-hydroxyphenyl)oxazolo(3',4'-1,6)pyrido(3,4-b)indole 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2006
012319922006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Many lignans and neolignans have served as lead compounds for the development of new drugs. Perhaps the best known example is… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
Fluoroquinolones are broad-spectrum antimicrobial agents that target type II topoisomerases. Many fluoroquinolones are highly… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1999
1999
The DNA sequence selectivity of topoisomerase II (top2)-DNA cleavage complexes was examined for the human (top2alpha), yeast, and… (More)
Is this relevant?
1998
1998
The synthesis and evaluation of azatoxin congeners possessing annealed aromatic frameworks are described. The compounds were… (More)
Is this relevant?
1997
1997
One approach to broadening the diversity of topoisomerase II-targeted anticancer agents is to generate novel compounds by… (More)
Is this relevant?
1997
1997
Eighteen analogues of the nonintercalative DNA topoisomerase II (topo II)-active epipodophyllotoxin-ellipticine hybrid, azatoxin… (More)
Is this relevant?
1995
1995
Azatoxin was rationally designed as a DNA topoisomerase II (top2) inhibitor [Leteurtre et al., Cancer Res 52: 4478-4483, 1992… (More)
Is this relevant?
1994
1994
BACKGROUND The cumulative cardiotoxicity of anthracyclines is thought to result from the generation of free radicals. New DNA… (More)
Is this relevant?
1993
1993
Azatoxin (NSC 640737) is a synthetic molecule that was rationally designed as a topoisomerase II inhibitor (Leteurtre et al… (More)
Is this relevant?
1992
1992
Azatoxin [NSC 640737-M; 5.R,11aS-1H,6H,3-one-5,4,11,11a-tetrahydro-5-(3,5-dimethoxy-4-hydr oxyphenyl) oxazolo (3',4':1,6)pyrido… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 6
  • figure 5
Is this relevant?